HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.

Abstract
Repeated administration of long acting analogues of gonadotrophin releasing hormone diminishes gonadal function and in men decreases testosterone concentrations; for this reason the effect of the analogue buserelin was studied in prostatic carcinoma. Twelve consecutive patients with newly diagnosed locally advanced or metastatic carcinoma of the prostate were treated. Each patient received intranasal buserelin in divided dosages of either 600 or 1000 micrograms daily. Suppression of the gonadotrophins and testosterone occurred in all patients. Objective and subjective signs of regression of disease were seen in nine patients. Buserelin offers an effective treatment of metastatic prostatic cancer without the side effects and cardiovascular risks associated with oestrogen treatment.
AuthorsJ H Waxman, J A Wass, W F Hendry, H N Whitfield, G M Besser, J S Malpas, R T Oliver
JournalBritish medical journal (Clinical research ed.) (Br Med J (Clin Res Ed)) Vol. 286 Issue 6374 Pg. 1309-12 (Apr 23 1983) ISSN: 0267-0623 [Print] England
PMID6404441 (Publication Type: Journal Article)
Chemical References
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Estradiol
  • Prolactin
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Buserelin
Topics
  • Administration, Intranasal
  • Aged
  • Buserelin
  • Estradiol (blood)
  • Follicle Stimulating Hormone (blood)
  • Gonadotropin-Releasing Hormone (administration & dosage, analogs & derivatives, therapeutic use)
  • Humans
  • Luteinizing Hormone (blood)
  • Male
  • Middle Aged
  • Prolactin (blood)
  • Prospective Studies
  • Prostatic Neoplasms (blood, drug therapy)
  • Testosterone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: